Bal Pharma Ltd.
| BSE: 524824 | Sector: Health care |
| NSE: BALPHARMA | ISIN Code: INE083D01012 |
| BSE 13:12 | 15 Apr | 62.50 |
-0.70 (-1.11%) |
OPEN
63.20 |
HIGH
64.70 |
LOW
59.05 |
| NSE 12:58 | 15 Apr | 63.25 |
0.10 (0.16%) |
OPEN
63.15 |
HIGH
64.80 |
LOW
60.75 |
| OPEN | 63.20 |
| PREVIOUS CLOSE | 63.20 |
| VOLUME | 3618 |
| 52-Week high | 73.00 |
| 52-Week low | 33.50 |
| P/E | 160.26 |
| Mkt Cap.(Rs cr) | 93 |
| Buy Price | 62.50 |
| Buy Qty | 35.00 |
| Sell Price | 63.50 |
| Sell Qty | 97.00 |
Bal Pharma Ltd. (BALPHARMA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 924.05 | 14.30 | 1.57 | 13266.48 |
| Cipla | 914.00 | 28.80 | 3.25 | 12659.15 |
| Sun Pharma.Inds. | 634.25 | 6.85 | 1.09 | 12531.93 |
| Dr Reddy's Labs | 4836.60 | 56.00 | 1.17 | 11850.40 |
| Lupin | 1046.10 | 8.95 | 0.86 | 11025.66 |
| Apollo Hospitals | 2949.85 | -28.55 | -0.96 | 9794.50 |
| Glenmark Pharma. | 548.05 | 36.10 | 7.05 | 6712.63 |
| Alkem Lab | 2722.95 | -31.65 | -1.15 | 6677.08 |
| Cadila Health. | 507.55 | 19.00 | 3.89 | 6347.40 |
| Torrent Pharma. | 2586.00 | 19.60 | 0.76 | 6168.44 |
| Divi's Lab. | 3802.10 | 81.85 | 2.20 | 5310.57 |
| Ipca Labs. | 2134.80 | -19.25 | -0.89 | 4337.82 |
| Piramal Enterp. | 1695.00 | -20.00 | -1.17 | 4219.19 |
| Alembic Pharma | 969.05 | -8.70 | -0.89 | 4132.55 |
| Abbott India | 15016.95 | 58.45 | 0.39 | 4093.14 |
| Glaxosmi. Pharma | 1449.80 | -5.30 | -0.36 | 3224.68 |
| Jubilant Pharmo | 726.90 | -13.90 | -1.88 | 3139.90 |
| Sanofi India | 8016.00 | -22.65 | -0.28 | 2901.10 |
| Laurus Labs | 435.00 | -4.65 | -1.06 | 2797.34 |
| Gland Pharma | 2495.20 | -36.85 | -1.46 | 2633.24 |
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
